Combating coronavirus disease 2019 at home: evaluation of home treatment approach for patients diagnosed with coronavirus disease 2019 with moderate and severe symptoms in Egypt

IF 0.2 Q4 RESPIRATORY SYSTEM Egyptian Journal of Chest Diseases and Tuberculosis Pub Date : 2022-10-01 DOI:10.4103/ecdt.ecdt_34_22
Mohamed Elbagalaty, S. Shawkat, Mohamed Mohamed
{"title":"Combating coronavirus disease 2019 at home: evaluation of home treatment approach for patients diagnosed with coronavirus disease 2019 with moderate and severe symptoms in Egypt","authors":"Mohamed Elbagalaty, S. Shawkat, Mohamed Mohamed","doi":"10.4103/ecdt.ecdt_34_22","DOIUrl":null,"url":null,"abstract":"Context Our study follows 34 patients during their home treatment after being diagnosed with moderate-severe coronavirus disease (COVID). The home treatment was chosen by the patients and their caregivers after being informed of the risks. Aim To evaluate the outcome of home treatment in patients with moderate to severe COVID who opted for home treatment instead of hospital admission. Patients and methods The retrospective study was conducted among patients diagnosed with SARS COV-2 with moderate to severe COVID who presented to our health care facility. We followed the patients from the initial diagnosis till the time of complete recovery. Results Overall, 87.5% of our moderate to severe COVID-infected patients were able to return to a full bill of health without the need for hospitalization. Age, BMI, or the presence of any comorbidity did not have a significant effect on the time till recovery or need for hospitalization in our sample. Majority of moderate to severe patients were not shown to need any hospitalization. Conclusion This sheds light on the fact that most moderate to severe COVID-infected patients may not require hospitalization and can be effectively managed at home under the supervision of a physician.","PeriodicalId":46359,"journal":{"name":"Egyptian Journal of Chest Diseases and Tuberculosis","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Chest Diseases and Tuberculosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ecdt.ecdt_34_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Context Our study follows 34 patients during their home treatment after being diagnosed with moderate-severe coronavirus disease (COVID). The home treatment was chosen by the patients and their caregivers after being informed of the risks. Aim To evaluate the outcome of home treatment in patients with moderate to severe COVID who opted for home treatment instead of hospital admission. Patients and methods The retrospective study was conducted among patients diagnosed with SARS COV-2 with moderate to severe COVID who presented to our health care facility. We followed the patients from the initial diagnosis till the time of complete recovery. Results Overall, 87.5% of our moderate to severe COVID-infected patients were able to return to a full bill of health without the need for hospitalization. Age, BMI, or the presence of any comorbidity did not have a significant effect on the time till recovery or need for hospitalization in our sample. Majority of moderate to severe patients were not shown to need any hospitalization. Conclusion This sheds light on the fact that most moderate to severe COVID-infected patients may not require hospitalization and can be effectively managed at home under the supervision of a physician.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在家抗击2019冠状病毒病:埃及2019冠状病毒病中重度患者家庭治疗方法评估
本研究对34例被诊断为中重度冠状病毒病(COVID)的患者进行了随访。家庭治疗是由患者及其护理人员在被告知风险后选择的。目的评价中重度新冠肺炎患者选择家庭治疗而非住院治疗的效果。患者和方法回顾性研究了在我们的卫生保健机构就诊的诊断为SARS COV-2并患有中重度COVID的患者。我们跟踪患者从最初诊断到完全康复。结果总体而言,87.5%的中重度covid - 19感染患者无需住院即可恢复健康。在我们的样本中,年龄、BMI或任何合并症的存在对恢复时间或住院治疗需求没有显著影响。大多数中度至重度患者不需要住院治疗。结论大多数中重度新冠肺炎患者可能不需要住院治疗,可以在医生的监督下在家中进行有效管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
46
审稿时长
22 weeks
期刊介绍: The journal will cover technical and clinical studies related to health, ethical and social issues in field of The Egyptian Journal of Chest Diseases and Tuberculosis aims to publish and inform readers and all chest physicians of the progress in medical research concerning all aspect of chest diseases. Publications include original articles review articles, editorials, case studies and reports which are relevant to chest diseases. The Journal also aims to highlight recent updates in chest medicine. . Articles with clinical interest and implications will be given preference.
期刊最新文献
Escalation to invasive mechanical ventilation in noninvasive ventilation failure: some insights about methodology Effect of physiotherapy and its frequency on the outcome of COVID-19 patients regarding acute care setting at isolation unit of Ain Shams University Role of interleukin-6 in coronavirus disease 2019 pneumonia: sensitive marker of inflammation, a predictor of ventilatory support and early marker of post-coronavirus disease lung fibrosis. A single center experience Diagnostic performance of transthoracic ultrasound in patients with pulmonary embolism Proportion and prognosis of ICU-admitted coronavirus disease 2019-infected patients in relation to all hospitalized cases in Abbasia Chest Hospital, Cairo
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1